The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (decapeptyl)

Fertility and Sterility

Volumn 65, Issue 2, 1996, Pages 342-348

  Lindsay, P C ^a   Shaw, R W ^a   Bennink, H J C ^a   Kicovic, P ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

add back therapy; endometriosis; GnRH agonists; Tibolone

Indexed keywords

GONADORELIN AGONIST; TIBOLONE; TRIPTORELIN;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOMETRIOSIS; FEMALE; HOT FLUSH; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; LAPAROSCOPY; LUMBAR SPINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWEATING; UTERUS MYOMA; VAGINA BLEEDING;

EID: 0030061173     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(16)58096-0     Document Type: Article

References (22)

1. R.W. Shaw Zoladex Endometriosis Study Team An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis Fertil Steril 58 1992 265 272
2. M.R. Henzl Gonadotropin-releasing hormone (GnRH) agonists in the management of endometriosis: a review Clin Obstet Gynecol 31 1988 840 856
3. C.P. West M.A. Lumsden S. Lawson J. Williamson D.T. Baird Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot Fertil Steril 48 1987 45 51
4. V. Perl J. Marquez A.V. Schally A.M. Comaru-Schally G. Leal S. Zacharias Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone Fertil Steril 48 1987 383 389
5. E.S. Surrey J.C. Gambone J.K.H. Lu H.L. Judd The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis Fertil Steril 53 1990 620 626
6. R.L. Barbieri Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy Am J Obstet Gynecol 162 1990 593 595
7. E.S. Surrey H.L. Judd Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial J Clin Endocrinol Metab 75 1992 558 563
8. R. Lindsay D.M. Hart A. Kraszeski Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing post-menopausal osteoporosis Br Med J 280 1980 1207 1209
9. P.M. Kicovic J. Cortes-Prieto M. Luisi S. Milojevic F. Franchi Placebo-controlled cross-over study of Org OD 14 in post menopausal women Reproduccion 6 1982 81 91
10. A.R. Genazzani L.J. Benedek Jaszmann D.M. Hart L. Andolsek P.M. Kicovic L. Tax Org OD 14 and the endometrium Maturitas 13 1991 243 251
11. L. Tax E.M. Goorissen P.M. Kicovic Clinical profile of Org OD 14 Maturitas 9 Suppl 1 1987 3 13
12. 6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients Fertil Steril 53 1990 401 406
13. A.D. LeBlanc H.J. Evans C. Marsh V. Schneider P.C. Johnson S.G. Jhingran Precision of dual photon absorptiometry measurements J Nucl Med 27 1986 1362 1365
14. The American Fertility Society Revised American Fertility Society classification of endometriosis: 1985 Fertil Steril 43 1985 351 352
15. A. Doberl A. Bergqvist S. Jeppsson A.I. Koskimies L. Ronnberg E. Segerbrand Regression of endometriosis following shorter treatment with, or lower dose of danazol Acta Obstet Gynecol Scand Suppl 123 1984 51 58
16. A. Vermeulen Testosterone in plasma. A physiopathological study Verh K Acad Geneeskd Belg 35 1973 95 180
17. P. Maouris M. Dowsett G. Rose D.K. Edmonds A new treatment for endometriosis Lancet 1 1989 1017 1018
18. D.K. Edmonds R. Howell Can hormone replacement therapy be used during medical treatment of endometriosis Br J Obstet Gynaecol 101 Supplement 10 1994 24 26
19. M.I. Cedars J.K. Lu D.R. Meldrum H.L. Judd Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate Obstet Gynecol 75 1990 641 645
20. J.M. Eidred P.J. Haynes E.J. Thomas A randomised double blind placebo controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethister-one Clin Endocrinol (Oxf) 37 1992 354 359
21. J. Rymer D. Crook M. Sidhu M. Chapman J.C. Stevenson Effects of tibolone on serum concentrations of lipoprotein(a) in postmenopausal women Acta Endocrinol (Copenh) 128 1993 259 262
22. P. von Dadelszen M.D.G. Gillmer M.D. Gray H.P. McEwan R.J.D. Pyper T.P. Rollason Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy Br J Obstet Gynaecol 101 1994 158 161